SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-068740
Filing Date
2024-06-05
Accepted
2024-06-05 17:23:52
Documents
6
Effectiveness Date
2024-06-05

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2416340d1_s8.htm S-8 81749
2 EXHIBIT 5.1 tm2416340d1_ex5-1.htm EX-5.1 11677
3 EXHIBIT 23.1 tm2416340d1_ex23-1.htm EX-23.1 2263
4 EXHIBIT 23.2 tm2416340d1_ex23-2.htm EX-23.2 2523
5 EX-FILING FEES tm2416340d1_ex-filingfees.htm EX-FILING FEES 14996
6 GRAPHIC tm2416340d1_ex5-1img001.jpg GRAPHIC 4019
  Complete submission text file 0001104659-24-068740.txt   120027
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279980 | Film No.: 241023062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)